The effects of cognitive behavioral therapy designed to manage anxiety in people with Alzheimer's disease

Main Article Content

Firas Abbas Fadhil


Alzheimer's disease is frequently associated with anxiety, which increase cognitive
deterioration. Using anxiety-management cognitive behavioral therapy may help to
halt cognitive decline, but more research needed to prove it. The objective of this
research is assess the impacts of a cognitive behavioral therapy targeting anxiety on
the cognitive deterioration of persons with Alzheimer's disease. Participants randomly
assigned to one of two groups: cognitive behavioral treatment (n = 7) or support group
(n = 9). Both therapies administered once a week for a total of eight weeks. Cognitive
measures (comprehensive cognition, verbal memory, semantic memory, fluency) and
an anxiety measure were used to assess the intervention's effects before (T1) and after
(T2). After 6 months (T3). Between T1 and T2, the results revealed that CBT had a
larger impact on general cognition and anxiety among participants (g = 0.75) than the
control group. Between T2 and T3, the support group had a larger improvement (g =
1.20) in participants' verbal fluency than the cognitive behavioral therapy group

Article Details